To further study whether p70S6K1 is required for gemcitabine-resistance in pancreatic cancer cells, we confirmed that knockdown of p70S6K1 using its shRNA significantly increased cell viability upon gemcitabine treatment in both cell lines (Figure 4E). The gene discussed is RPS6KB1; the disease is familial pancreatic carcinoma.